Luigi Xerri
Principal investigator, leads VENATORX PHARMACEUTICALS INC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$7.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $7.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 11, 2019 | NIH | SBIR Phase II Advancement to IND of novel BLI for pairing with cefixime | $1.0M | VENATORX PHARMACEUTICALS INC |
| Jul 9, 2018 | NIH | SBIR Phase II Advancement to IND of novel BLI for pairing with cefixime | $1.0M | VENATORX PHARMACEUTICALS INC |
| Aug 7, 2017 | NIH | SBIR Phase II Advancement to IND of novel BLI for pairing with cefixime | $1.0M | VENATORX PHARMACEUTICALS INC |
| Aug 7, 2017 | NIH | SBIR Phase II Advancement to IND of novel BLI for pairing with cefixime | $3.0M | VENATORX PHARMACEUTICALS INC |
| Aug 6, 2015 | NIH | SBIR Phase II Phase II SBIR: Responding to NDM-1 - Advancement of a new MBL inhibitor to IND | $1.0M | VENATORX PHARMACEUTICALS INC |
Peer ranks
Federal funding#141
Awards as PI#417
Patents#273
Companies
- VENATORX PHARMACEUTICALS INCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.